This combination markedly increased the number of tumor-infiltrating CD8α<sup>+</sup> T cells and NK1.1<sup>+</sup> cells.<h4>Conclusions</h4>These results suggest that BIX-01294 is more effective in vivo than UNC0642 due to its favorable PK profile and superior cellular uptake. This evidence concerns the gene CD8A and neoplasm.